Table 1.

A summary of the clinical findings and outcomes of patients who underwent high-dose radiotherapy for inoperable malignant maxillary sinus-involving tumor

Patient No.	Age, years	Gender	Type of tumor				Tumor grading			Concurrent chemotherapy	Interval from RT to 1st follow-up visit1			Interval from RT to onset of symptoms2
1	49.7	male	G1 SCC				T4a N0 M0		Yes		17.4 months			16.0 months
2	75.3	female	<G1 SCC				T4a N0 M0		No		5.5 months			4.0 months
3	82.2	male	G2/G3 SCC				T4a N0 M0		No		10.0 months			4.0 months
4	71.1	female	G3 undifferentiated				T4a N0 M0		Yes		0.7 months			−0.3 months
5	63.3	male	G2 SCC				T4b N2b M0		Yes		0.3 months			−0.1 months
6	59.4	male	G1/G2 SCC				T4b N2c M0		Yes		2.8 months			1.5 months
7	60.7	male	G1 SCC				T4a N2b M0		Yes		0.6 months			−0.1 months

Patient No.	Complications								Initial CDVA	Final CDVA	Surgery			Systemic outcome
	LMD	DED	NK	LSCD	CC	glaucoma	RR	CP			TK	AMT	tarsorrhaphy
1	+	+	III	−	−	−	−	+	6/12	PL	+	−	−	deceased
2	+	+	III	−	+	−	−	+	6/18	HM	−	+	+	disease-free
3	+	+	I	+	+	+	+	−	6/400	PL (before	−	+	−	disease-free
4	+	+	III	+	+	+	−	+	6/18	evisceration) CF	+	+		disease-free
5	+	+	III	+	+	−	−	+	6/36	6/18	+	+	+	disease-free
6	+	+	I	−	−	−	−	−	6/9	6/6	−	−	−	deceased
7	+	+	II	−	+	−	−	−	6/9	6/9	−	+	+	recurrence

RT, radiotherapy; SCC, squamous cell carcinoma; CDVA, corrected-distance visual acuity; LMD, lid margin disease (including madarosis, meibomianitis, keratinization, and loss of meibomian glands); DED, dry eye disease; NK, neurotrophic keratopathy; LSCD, limbal stem cell deficiency; CC, cicatricial conjunctivitis; RR, radiation retinopathy; CP, corneal perforation; TK, tectonic keratoplasty; AMT, amniotic membrane transplant; G1, grade 1 (well-differentiated); G2, grade 2 (moderately differentiated); G3, grade 3 (poorly differentiated).

¹The interval between the completion of radiotherapy and the first post-radiotherapy ophthalmic visit.

²The interval between the completion of radiotherapy and the onset of self-reported post-radiotherapy symptoms.